NCT04727723 - Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in GEP-NETs | Biotech Hunter

Enrollment

164

Participants

Timeline

Start Date

March 9, 2021

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Gastroenteropancreatic Neuroendocrine Tumor

Interventions

DRUG

Lutathera®

Treatment with Lutathera® will be independent from participation in this observational study and must not be initiated for the purpose of participating in this study. The decision to treat patients with Lutathera® will occur before patients are enrolled in the study.

Trial Locations (18)

Unknown

Novartis Investigative Site, Alessandria

Novartis Investigative Site, Bologna

Novartis Investigative Site, Brescia

Novartis Investigative Site, Cona

Novartis Investigative Site, Florence

Novartis Investigative Site, Latina

Novartis Investigative Site, Meldola

Novartis Investigative Site, Messina

Novartis Investigative Site, Milan

Novartis Investigative Site, Napoli

Novartis Investigative Site, Negrar

Novartis Investigative Site, Padua

Novartis Investigative Site, Pisa

Novartis Investigative Site, Reggio Emilia

Novartis Investigative Site, Rionero in Volture

Novartis Investigative Site, Roma

Novartis Investigative Site, Rozzano

Novartis Investigative Site, Torino